July 22, 2025Disease and DiagnosisOpen Access

Exploring the Relationship Between Clinical and Paraclinical Findings and the Severity of Ulcerative Colitis and Disease Extension

View Full Paper

Ask AI

Bookmark

Higher levels of fecal calprotectin and ESR are associated with severe ulcerative colitis, indicating worse disease outcomes.
Key factors affecting severity include abdominal pain, bloody diarrhea, and immunotherapy history, influencing treatment approaches.
This cross-sectional analysis involved 299 ulcerative colitis patients over one year, emphasizing collaborative studies for better understanding.
Findings highlight the importance of monitoring biomarkers like fecal calprotectin and ESR for effective management of ulcerative colitis.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cross-sectional analysis shows fecal calprotectin and ESR relate to severity in ulcerative colitis, suggesting targeted therapies may help manage symptoms.

Cite This Study

Basham et al. (2025) studied this question.

synapsesocial.com/papers/68af475aad7bf08b1ead41bc https://doi.org/10.34172/ddj.1663

View Full Paper

Ask AI

Bookmark

Implication

Cross-sectional analysis shows fecal calprotectin and ESR relate to severity in ulcerative colitis, suggesting targeted therapies may help manage symptoms.

Exploring the Relationship Between Clinical and Paraclinical Findings and the Severity of Ulcerative Colitis and Disease Extension

Key Points

Discussion

Implication

Cite This Study

Exploring the Relationship Between Clinical and Paraclinical Findings and the Severity of Ulcerative Colitis and Disease Extension

Key Points

Discussion

Implication

Cite This Study